Determination of depression, anxiety and stress (DAS) levels in patients with atopic dermatitis: a case-control study

Basit Öğe Kaydı
dc.authoridDuran, Songul/0000-0002-2565-7784
dc.authorwosidDuran, Songül/AAA-6265-2021
dc.contributor.authorDuran, Songul
dc.contributor.authorAtar, Emine
dc.date.accessioned2024-06-12T10:52:47Z
dc.date.available2024-06-12T10:52:47Z
dc.date.issued2020
dc.departmentTrakya Üniversitesien_US
dc.description.abstractThe present study was aimed at comparing depression, anxiety and stress (DAS) levels of individuals with atopic dermatitis with those of the individuals without atopic dermatitis, and to examine the DAS levels of the patients with atopic dermatitis in terms of their socio-demographic characteristics. Case control study conducted in a city in western Turkey. The present study in which the relational screening model was used was conducted with patients with atopic dermatitis who presented to the Dermatology Clinic/Polyclinic of a university hospital and healthy subjects, and volunteered to participate in the study. The study conducted between December 2017 and February 2018 included 150 people (75 healthy subjects, 75 patients with atopic dermatitis). To collect the study data, the participants were administered the Socio-demographic Characteristics Questionnaire prepared by the researcher and the Depression, Stress and Anxiety Scale (DASS-42). No significant difference was determined between the mean DASS scores obtained by the atopic dermatitis patients and those obtained by the healthy subjects in the control group (p > 0.05). Of the atopic dermatitis patients, 58.7%, 82.3% and 49.3% were within the normal ranges in terms of the mean scores they obtained from the stress, depression and anxiety subscales respectively. In the present study, the mean scores obtained from the depression and anxiety subscales by working atopic dermatitis patients were higher than those obtained by the nonworking patients (p < 0.05). The mean scores obtained from the stress subscale by the smokers with atopic dermatitis were higher than those obtained by the non-smokers with atopic dermatitis.en_US
dc.identifier.doi10.1080/13548506.2019.1710545
dc.identifier.endpage1163en_US
dc.identifier.issn1354-8506
dc.identifier.issn1465-3966
dc.identifier.issue9en_US
dc.identifier.pmid31889448en_US
dc.identifier.scopus2-s2.0-85078602856en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage1153en_US
dc.identifier.urihttps://doi.org/10.1080/13548506.2019.1710545
dc.identifier.urihttps://hdl.handle.net/20.500.14551/18835
dc.identifier.volume25en_US
dc.identifier.wosWOS:000504955000001en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherRoutledge Journals, Taylor & Francis Ltden_US
dc.relation.ispartofPsychology Health & Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAtopic Dermatitisen_US
dc.subjectDepressionen_US
dc.subjectAnxietyen_US
dc.subjectStressen_US
dc.subjectQuality-Of-Lifeen_US
dc.subjectSkin-Diseaseen_US
dc.subjectSymptomsen_US
dc.subjectChildrenen_US
dc.subjectAdultsen_US
dc.subjectImpacten_US
dc.titleDetermination of depression, anxiety and stress (DAS) levels in patients with atopic dermatitis: a case-control studyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu